Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer.
Dahut WL, Gulley JL, Arlen PM, Liu Y, Fedenko KM, Steinberg SM, Wright JJ, Parnes H, Chen CC, Jones E, Parker CE, Linehan WM, Figg WD.
Dahut WL, et al. Among authors: arlen pm.
J Clin Oncol. 2004 Jul 1;22(13):2532-9. doi: 10.1200/JCO.2004.05.074.
J Clin Oncol. 2004.
PMID: 15226321
Clinical Trial.